Pharmaceutical simulation software company Simulations Plus announced Thursday the University+ program, which offers one year of free access to Simulations Plus programs for students and educators at accredited universities worldwide.

The program, which is part of the Lancaster company’s 25th anniversary celebration, is renewable for students and educators as long as eligibility requirements are met.


“The goal of the new University+ Program is to increase (modeling and simulation) education and publications that will promote the next generation of scientists by setting them up today for success tomorrow,” John DiBella, Simulations Plus division president, said in a statement.


In addition to software access, the University+ program will offer an internship and postdoctoral program that, according to DiBella, will give students access to hands-on experience and funded postdoctoral opportunities with Simulations Plus.


DiBella added that students may be able to gain full-time employment careers “where they can apply model informed drug development skills and methods with Simulations Plus, industry, academia or government agencies.”


Shares of Simulations Plus closed down 93 cents, or 2.4 percent, to $37.89 on the Nasdaq Thursday, a day when the market closed up a fraction of a percent.